Even though BiP upregulation is beneficial to immune responses as it activates signal transducers that mediate cytokine and antibody gene expression; similarly, its downregulation has been associated with benefits in cancer suppression that could be a target of choice in studies such as for B cell lymphoma. The gene discussed is HSPA5; the disease is cancer.